EX-16.1 2 d907643dex161.htm EX-16.1 EX-16.1
LOGO      

Deloitte LLP

939 Granville Street,

Vancouver V6Z 1L3

Canada

 

Tel: 604-669-4466

Fax: 604-685-0395

www.deloitte.ca

March 20, 2020

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549-7561

Dear Sirs/Madams:

We have read the statements made by Neoleukin in Item 4.01 of Neoleukin Therapeutics, Inc.’s Current Report on Form 8-K dated March 20, 2020, and we agree with the statements concerning our Firm in such Form 8-K.

Yours truly,

/s/ DELOITTE LLP

Chartered Professional Accountants

Vancouver, Canada